Stockreport

Dosing underway in study of Theravance drug for COVID-19 [Seeking Alpha]

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations
PDF Theravance Biopharma (NASDAQ:TBPHdosesPhase 1 study of TD-0903The company received approval of TD-0903's initial Clinical Trial Application (CTA) in the UK for the Phase [Read more]